tiprankstipranks
Race Oncology Ltd. (AU:RAC)
ASX:RAC
Australian Market
Holding AU:RAC?
Track your performance easily

Race Oncology Ltd. (RAC) Income Statement

16 Followers

Race Oncology Ltd. Income Statement

Last quarter (Q4 2022), Race Oncology Ltd.'s total revenue was AU$―, a decrease of ― from previous quarter. In Q4, Race Oncology Ltd.'s net income was AU$―. See Race Oncology Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 22Jun 21Jun 20Jun 19
Total Revenue
-----
Cost of Revenue
-----
Gross Profit
-----
Operating Expense
-AU$ 11.96MAU$ 6.78MAU$ 4.11MAU$ 3.91M
Operating Income
-AU$ -11.96MAU$ -6.78MAU$ -4.11MAU$ -3.91M
Net Non Operating Interest Income Expense
-AU$ 53.91KAU$ 18.85KAU$ 9.32KAU$ 17.36K
Other Income Expense
-AU$ 707.81KAU$ 424.88KAU$ 256.44KAU$ 228.50K
Pretax Income
-AU$ -11.20MAU$ -6.34MAU$ -3.85MAU$ -3.66M
Tax Provision
-AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
-AU$ -11.20MAU$ -6.34MAU$ -3.85MAU$ -3.66M
Basic EPS
-AU$ -0.07AU$ -0.05AU$ -0.04AU$ -0.05
Diluted EPS
-AU$ -0.07AU$ -0.05AU$ -0.04AU$ -0.05
Basic Average Shares
-AU$ 153.31MAU$ 130.96MAU$ 106.59MAU$ 79.84M
Diluted Average Shares
-AU$ 153.31MAU$ 130.96MAU$ 106.59MAU$ 79.84M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
-----
Net Income From Continuing And Discontinued Operation
-AU$ -11.20MAU$ -6.34MAU$ -3.85MAU$ -3.66M
Normalized Income
-AU$ -11.20MAU$ -6.34MAU$ -3.85MAU$ -3.66M
Interest Expense
-----
EBIT
-AU$ -11.96MAU$ -6.78MAU$ -4.11MAU$ -3.91M
EBITDA
-AU$ -11.68MAU$ -6.50MAU$ -3.83MAU$ -3.62M
Currency in AUD

Race Oncology Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis